Latest S-1 registration statements

Longeveron Inc. is offering up to 2,461,538 shares of Class A Common Stock along with warrants in a public offering to fund clinical trials and general corporate purposes.

Nascent Biotech aims to raise capital for Phase 2 clinical trials and administrative expenses through a self-underwritten public offering of 20,000,000 shares of common stock at $0.15 per share.

Artificial Intelligence Technology Solutions (AITX) has filed a registration statement for the resale of up to 2.5 billion common shares by GHS Investments, with the company potentially receiving up to $5.3 million from sales to GHS.

Venus Concept has filed a registration statement for the resale of up to 874,990 shares of its common stock by selling stockholders, which are issuable upon the exercise of outstanding warrants.

BioRestorative Therapies has filed a registration statement for the potential resale of up to 2,513,686 shares of its common stock by existing securityholders.

Ealixir Inc., an online reputation management company, files an S-1/A registration statement for a public offering, aiming to list its Common Stock on a national securities exchange and expand its services.

Calidi Biotherapeutics files an amendment to its Form S-1 registration statement to include updated exhibits and legal opinions related to its proposed offering.

Awaysis Capital, a real estate management and hospitality company, has filed an amendment to its Form S-1 registration statement for the resale of up to 60,031,866 shares of its common stock by selling shareholders.

Mustang Bio files an amendment to its S-1 registration statement to include exhibits related to securities purchase agreements and warrants.

Loar Holdings Inc. files an S-1 registration statement detailing a voting agreement among key shareholders and its transition to a controlled company post-IPO.

Volato Group, Inc. has filed an amendment to its Form S-1 registration statement, detailing the potential offer and sale of up to 23,318,122 shares of common stock and 15,226,000 warrants by selling stockholders.

Soligenix, Inc. plans to raise up to $10 million through a public offering of common stock and warrants to fund research, development, and general corporate purposes.

Pinstripes Holdings, Inc. files an amendment to its Form S-1 registration statement related to the issuance and resale of common stock and warrants.

Worksport Ltd. has filed a registration statement for the resale of up to 7,700,264 shares of common stock issuable upon the exercise of outstanding warrants.

QT Imaging Holdings aims to raise capital through the potential sale of common stock and warrants, as detailed in its S-1 filing.

UL Solutions Inc. establishes a long-term incentive plan, granting restricted stock units to non-employee directors to align their interests with the company's long-term performance.

AEON Biopharma files for a potential $357 million resale of common stock and warrants, while also eyeing potential capital from warrant exercises.

Mobix Labs amends its business combination agreement to address option and warrant conversions and files an S-1 registration statement for a potential $100 million stock offering with B. Riley Principal Capital II.

Pinstripes Holdings files an updated S-1 registration statement to address SEC comments and register shares for warrant exercise and resale by selling securityholders.

Rubrik, Inc. prepares for its initial public offering by amending and restating its investors' rights agreement, detailing registration rights, covenants, and other key provisions.

PACS Group, Inc. files an amendment to its S-1 registration statement, detailing changes to its bylaws and confirming its application to list on the NYSE under the ticker symbol 'PACS'.

Kenilworth Systems Corporation has filed a registration statement for the resale of up to 25,531,228 shares of its common stock by selling stockholders.

American Bear Logistics Corp. secures a warehouse lease in Southlake, Texas, while simultaneously preparing for a potential initial public offering.

Microbot Medical has filed an amendment to its Form S-1 registration statement, pertaining to the resale of up to 1,005,965 shares of its common stock by selling stockholders, primarily related to the settlement of a lawsuit.

Contineum Therapeutics, a clinical-stage biopharmaceutical company, is seeking to raise approximately $150 million through an initial public offering to advance its pipeline of therapies for neuroscience, inflammation, and immunology indications.

Calidi Biotherapeutics plans to offer common stock units and pre-funded warrant units to raise capital.

Richtech Robotics has filed an amendment to its S-1 registration statement, outlining the potential resale of up to 12,983,208 shares of Class B common stock by YA II PN, Ltd. following a standby equity purchase agreement.

Panbela Therapeutics is registering the resale of up to 255,600 shares of its common stock by selling securityholders, while facing challenges with Nasdaq listing compliance.

CleanCore Solutions, Inc. files Amendment No. 7 to its Form S-1 registration statement, primarily to include updated exhibits.

Aptevo Therapeutics is launching a public offering of common stock and warrants to raise capital for clinical programs and general corporate purposes.